IM Cannabis Corp C.IMCC

Alternate Symbol(s): IMCC

Healthcare

IM Cannabis Corp. is a Canada-based international cannabis company that provides cannabis products to medical patients in Israel and Germany. The Company's ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel. In Germany, the Company operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. It offers four different product lines, leading with the Craft Collection which offers the highest quality Canadian craft cannabis flower. The Company's other product lines include Top-Shelf Collection, Signature Collection and Full Spectrum Extracts. The Company's brands include The WAGNERS, BLKMKT, LOT420, and The PICO collection (minis).

CSE:IMCC - Post by User

IM Cannabis Corp > Record after record

<< Previous

Bullboard Posts

Next >>

Comment by RockMaschineon May 17, 2021 4:16pm

166 Views

Post# 33215947

RE:Record after record

$8 million revenue and less than a million ebidta loss. Expecting double again to $17-19 million for Q2 once Trichome gets counted. Not even including the 5-6 that MYM will bring in once that closes. Still growing into its market cap but the prospects here are huge.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?